Press Release

SentiAR is a cultivate(MD) portfolio company

SentiAR Announces Close of $8.5 million Series B Financing

Press Release / April 11, 2023

Expand Partnerships and Clinical Deployments St. Louis, Missouri, April 11th, 2023 — SentiAR, Inc. a St. Louis, Missouri based pioneer in using Augmented Reality (AR) visualization technology for medical procedures, has closed an $8.5 million Series B financing. The financing was led by cultivate (MD) Ventures and joined by MedVenture Partners alongside several insider investors, […]

SentiAR Announces Close of $8.5 million Series B Financing Read More »

Shoulder Innovations Announces Oversubscribed $42 million Series D Financing

Press Release / March 6, 2023

Grand Rapids, Mich., March 6, 2023 — Shoulder Innovations Inc. (SI), a Grand Rapids, Michigan based leader in the shoulder replacement implant market, announced closing on an oversubscribed $42 million Series D financing. SI is a privately-held medical device company with a broad team of successful innovators in the shoulder space. The financing was led by Gilde Healthcare Partners, a

Shoulder Innovations Announces Oversubscribed $42 million Series D Financing Read More »

cultivate(MD) Capital Funds Portfolio Company SPDx (Sterile Processing Express) Announces Julius Heil As CEO

Press Release / March 1, 2023

Grand Rapids, Mich., March 1, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Grand Rapids-based SPDx has hired Julius Heil in the role of CEO. Mr. Heil brings over 30 years’ experience in healthcare and logistics

cultivate(MD) Capital Funds Portfolio Company SPDx (Sterile Processing Express) Announces Julius Heil As CEO Read More »

cultivate (MD) Capital Funds Portfolio Company Virtual Incision Announces Completion of Clinical Study Enrollment for its MIRA® Platform

Press Release / February 28, 2023

FDA decision supported by an interim clinical study report on patient safety Grand Rapids, Mich., February 28, 2023— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Lincoln, Nebraska-based Virtual Incision Corporation, has completed its U.S. Food and Drug

cultivate (MD) Capital Funds Portfolio Company Virtual Incision Announces Completion of Clinical Study Enrollment for its MIRA® Platform Read More »

cultivate(MD) Capital Funds Announces Portfolio Company Embody’s Acquisition by Zimmer Biomet Holdings, Inc.

Press Release / January 10, 2023

Grand Rapids, Mich., January 10th, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Norfolk, VA-based Embody, Inc., a privately held medical device company focused on soft tissue healing, has reached an agreement with Zimmer Biomet Holdings, Inc., a global

cultivate(MD) Capital Funds Announces Portfolio Company Embody’s Acquisition by Zimmer Biomet Holdings, Inc. Read More »

Zimmer Biomet to Acquire Embody, Inc.

Press Release / January 5, 2023

WARSAW, Ind., Jan. 5, 2023 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it has reached a definitive agreement to acquire Embody, Inc., a privately-held medical device company focused on soft tissue healing, for $155 million at closing and up to an additional $120 million

Zimmer Biomet to Acquire Embody, Inc. Read More »